Showing results 1 to 10 of 10
Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer
Journal:Clinical and Experimental Metastasis
E-cadherin upregulation as a therapeutic goal in cancer treatment
Journal:Mini-Reviews in Medicinal Chemistry
Evidence of a novel docetaxel sensitizer, garlic derived S-allylmercaptocysteine, in the suppression of hormone refractory prostate cancer
Proceeding/Conference:AACR Centennial Conference
Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer
Journal:International Journal of Cancer
Garlic derived compounds, S-allylcysteine (SAC) and S-allylmercaptocysteine (SAMC), synergise with Docetaxel to suppress growth of androgen refractory prostate cancer.
Proceeding/Conference:BIT life Science’s 1st World Cancer Congress, June 12-17 2008, Shanghai, China.
Garlic derived compounds, SAC and SAMC, synergise with docetaxel to inhibit the growth of hormone refractory prostate cancer
Proceeding/Conference:Proceeding of 5th APICA International Congress of Anatomists and the 8th Iranian congress of Anatomical Sciences, May 16-19, 2008. Tehran, Iran.
Garlic extract synergizes with docetaxel in suppressing the hormone refractory prostate cancer growth
Proceeding/Conference:Proceeding of 12th World Congress on Advances in Oncology and 10th International Symposium on Molecular Medicine held in Hersonissos, Crete, Greece from October 11-13, 2007.Int J Mol Medicine
Garlic extracts working in concert with docetaxel to suppress the growth of androgen independent prostate cancer.
Proceeding/Conference:XIX International Symposium on Morphological Sciences. Budapest, Hungary. 19-23/8 2007. Acta Biologica Szegediensis
Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer
Journal:Clinical Cancer Research
Potent suppression of distant metastasis by garlic compound S-allylmercaptocysteine in an in vivo androgen independent prostate cancer model
Proceeding/Conference:American Association for Cancer Research Conference on Innovations in Prostate Cancer Research